Phase I pharmacodynamic (PD) and pharmacokinetic (PIK) analysis of the sorafenib (S) and erlotinib (E) combination in patients with advanced solid tumors

被引：0
|
作者：
Le Tourneau, C. [1 ]
Duran, I. [1 ]
Chen, E. [1 ]
Wang, L. [2 ]
Tsao, M. [3 ]
Hedley, D. [3 ]
Phan, N. [3 ]
Do, T. [3 ]
Metser, U. [4 ]
Siu, L. [1 ]
机构：
[1] Princess Margaret Hosp, Dept Med Oncol, Drug Dev Program, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada
[3] Princess Margaret Hosp, Correlat Studies Dept, Toronto, ON M4X 1K9, Canada
[4] Princess Margaret Hosp, Dept Radiol, Toronto, ON M4X 1K9, Canada
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72344-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [41] Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
    Steeghs, Neeltje
    Eskens, Ferry A. L. M.
    Gelderblom, Hans
    Verweij, Jaap
    Nortier, Johan W. R.
    Ouwerkerk, Jan
    van Noort, Conny
    Mariani, Mariangela
    Spinelli, Riccardo
    Carpinelli, Patrizia
    Laffranchi, Bernard
    de Jonge, Maja J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : 5094 - 5101
  • [42] Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
    D Alan Anthoney
    Jay Naik
    Iain RJ MacPherson
    Donna Crawford
    John M Hartley
    Janet A Hartley
    Tomohisa Saito
    Masaichi Abe
    Keith Jones
    Masanori Miwa
    Christopher Twelves
    TRJ Evans
    BMC Cancer, 12
  • [43] Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
    Anthoney, D. Alan
    Naik, Jay
    MacPherson, Iain R. J.
    Crawford, Donna
    Hartley, John M.
    Hartley, Janet A.
    Saito, Tomohisa
    Abe, Masaichi
    Jones, Keith
    Miwa, Masanori
    Twelves, Christopher
    Evans, T. R. J.
    BMC CANCER, 2012, 12
  • [44] A phase I study of 5-azacytidine () and erlotinib (E) for patients (pt) with advanced solid tumors
    Verschraegen, Claire
    Muller, Carolyn
    Bauman, Julie
    Rutledge, Teresa
    Jones, Dennie
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [45] A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors
    Sanoff, Hanna K.
    Davies, Janine M.
    Walko, Christine
    Irvin, William
    Buie, Larry
    Keller, Kimberly
    Ivanova, Anastasia
    Chiu, Wing-Keung
    O'Neil, Bert H.
    Stinchcombe, Thomas E.
    Dees, E. Claire
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 978 - 983
  • [46] A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors
    Hanna K. Sanoff
    Janine M. Davies
    Christine Walko
    William Irvin
    Larry Buie
    Kimberly Keller
    Anastasia Ivanova
    Wing-Keung Chiu
    Bert H. O’Neil
    Thomas E. Stinchcombe
    E. Claire Dees
    Investigational New Drugs, 2011, 29 : 978 - 983
  • [47] Dual inhibition of the MAPK pathway by combination targeted therapy: a phase I trial of sorafenib (SOR) and erlotinib (ERL) in advanced solid tumors
    Duran, I.
    Hotte, S.
    Chen, E.
    Hirte, H.
    MacLean, M.
    Turner, S.
    Pond, G.
    Wright, J.
    Dancey, J.
    Siul, L.
    EJC SUPPLEMENTS, 2006, 4 (12): : 167 - 167
  • [48] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Allegrini, Giacomo
    Di Paolo, Antonello
    Cerri, Elisa
    Cupini, Samanta
    Amatori, Federica
    Masi, Gianluca
    Danesi, Romano
    Marcucci, Lorenzo
    Bocci, Guido
    Del Tacca, Mario
    Falcone, Alfredo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 585 - 593
  • [49] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
    Giacomo Allegrini
    Antonello Di Paolo
    Elisa Cerri
    Samanta Cupini
    Federica Amatori
    Gianluca Masi
    Romano Danesi
    Lorenzo Marcucci
    Guido Bocci
    Mario Del Tacca
    Alfredo Falcone
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 585 - 593
  • [50] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Lin, Chia-Chi
    Calvo, Emiliano
    Papadopoulos, Kyriakos P.
    Patnaik, Amita
    Sarantopoulos, John
    Mita, Alain C.
    Preston, Glenn G.
    Mita, Monica M.
    Rodon, Jordi
    Mays, Theresa
    Yeh, I-Tien
    O'Rourke, Pat
    Takimoto, Chris H.
    Dancey, Janet E.
    Chen, Helen
    Tolcher, Anthony W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1065 - 1071
12345